Rational therapy for relapsing multiple sclerosis
- 1 May 2003
- journal article
- reflection and-reaction
- Published by Elsevier in The Lancet Neurology
- Vol. 2 (5) , 271-272
- https://doi.org/10.1016/s1474-4422(03)00375-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Interferons in relapsing remitting multiple sclerosis: a systematic reviewThe Lancet, 2003
- A Controlled Trial of Natalizumab for Relapsing Multiple SclerosisNew England Journal of Medicine, 2003
- Inflammation in multiple sclerosis: the good, the bad, and the complexThe Lancet Neurology, 2002
- Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trialThe Lancet, 2002
- Copaxone’s effect on MRI-monitored disease in relapsing MS is reproducible and sustainedNeurology, 2002
- Statins as immunomodulatorsNeurology, 2002
- Differential mechanisms of action of interferon-β and glatiramer acetate in MSNeurology, 2002
- Multiple sclerosisThe Lancet, 2002
- Beneficial effect of modified peptide inhibitor of α4 integrins on experimental allergic encephalomyelitis in Lewis ratsJournal of Neuroscience Research, 2001
- Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1997